Partner Article
Paracetamol may reduce cancer risk
Using paracetamol regularly could reduce the risk of ovarian cancer by almost a third, according to scientists. A research team from Athens University studied 746,000 women over a six-year period, and found that the risk of cancer fell by 30% when the women took paracetamol regularly. However, the scientists stressed that more research was needed, and women should not take the medicine as a way to guard against the disease due to the risks of long-term paracetamol use - including liver and chronic kidney failure. “Ovarian cancer remains the most fatal gynecological malignancy” says Dr Bonovas of Athen University. “Its high mortality rate – mainly due to a combination of ineffective screening and the limited success of therapies for advanced disease - makes ovarian cancer a major health concern. “Strategies that focus on prevention may therefore provide the most rational approach for reducing deaths from this form of cancer. “Because paracetamol is so widely used, a link with a decreased risk of ovarian cancer could have important public health implications.”
This was posted in Bdaily's Members' News section by Ruth Mitchell .
Enjoy the read? Get Bdaily delivered.
Sign up to receive our popular morning National email for free.
Are you a meat proxy?
Engaging the five-generation workplace
Talent is an asset, not an operational resource
Taking advantage of the opportunities ahead
Accountability isn’t the enemy of empathy
Act now to avoid a last-minute tax scramble
How inner-city living can transform a city by the sea
Artificial intelligence's value is the time it gives back
Why we must break the magnetic pull of London
AI scepticism is healthy - inaction isn't
What does NPPF mean for planning gain and pricing?
What new NPPF rules mean for landowners